Jennison Associates
STDY

Jennison Associates’s SteadyMed Ltd STDY Stock Holding History

Jennison Associates’s Portfolio STDY Stock Details STDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-355,660
Closed -$2.06M – 678
2017
Q1 		$2.06M Hold
355,660
– – ﹤0.01% 541
2016
Q4 		$942K Buy
355,660
+722
+0.2% +$2.46K ﹤0.01% 618
2016
Q3 		$1.27M Sell
354,938
-1,102
-0.3% -$3.77K ﹤0.01% 573
2016
Q2 		$1.15M Buy
356,040
+15
+0% +$52 ﹤0.01% 563
2016
Q1 		$876K Buy
356,025
+1,755
+0.5% +$4.37K ﹤0.01% 565
2015
Q4 		$1.16M Sell
354,270
-77,985
-18% -$235K ﹤0.01% 581
2015
Q3 		$1.53M Buy
432,255
+1,159
+0.3% +$5.28K ﹤0.01% 612
2015
Q2 		$2.29M Buy
431,096
+1,143
+0.3% +$9.23K ﹤0.01% 613
2015
Q1 		$3.65M Buy
+429,953
New +$3.68M ﹤0.01% 544

Other funds holding STDY

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jennison Associates's STDY Position: Q2 2017 in Review

Jennison Associates sold out of SteadyMed Ltd (STDY) in Q2 2017, closing a stake of 355,660 shares — an estimated $2.06M sold.

Jennison Associates first reported a position in STDY in Q1 2015 and held it in 9 quarters. The position peaked at $3.65M in Q1 2015. 26 funds tracked by Wall St. Rank hold STDY as of Q2 2017.

  • Jennison Associates reported no remaining SteadyMed Ltd position as of Q2 2017 after selling out during the quarter.
  • Jennison Associates sold 355,660 SteadyMed Ltd shares in Q2 2017, an estimated $2.06M.
  • Jennison Associates first reported a position in SteadyMed Ltd in Q1 2015 and held it in 9 quarters.
  • Jennison Associates's SteadyMed Ltd position peaked at $3.65M in Q1 2015.
  • 26 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q2 2017.

Based on Jennison Associates's 13F filing for Q2 2017, filed 4 Aug 2017.